H-1B sponsorship profile: KBI Biopharma, Inc. Across U.S. Department of Labor LCA disclosures, KBI Biopharma, Inc filed 63 Labor Condition Applications covering 63 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 93.7% (59 certified of 63 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on KBI Biopharma, Inc’s H-1B petitions range from $45,000 at the low end to $222,500 at the high end, with a petition-weighted average of $106,825. That range reflects the mix of occupations the company sponsors, led by Scientist I (7 petitions at $92,303 avg), followed by Scientist I/Data Reviewer and Research Associate II. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. KBI Biopharma, Inc is headquartered in Durham, NC under NAICS code 5417, and places H-1B workers across 4 states, most heavily in NC, CO, WA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where KBI Biopharma, Inc ranks. By H-1B petition volume, KBI Biopharma, Inc is #3,755 of 119,880 employers nationally and #106 of 2,377 employers headquartered in NC. Both ranks are computed live from the same underlying petition counts, not a separate estimate.